{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T00:38:57Z","timestamp":1778891937743,"version":"3.51.4"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Pink Pumpkin Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1007\/s10549-016-3729-8","type":"journal-article","created":{"date-parts":[[2016,2,25]],"date-time":"2016-02-25T09:22:20Z","timestamp":1456392140000},"page":"33-43","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Mutations in PIK3CA sensitize breast cancer cells to physiologic levels of aspirin"],"prefix":"10.1007","volume":"156","author":[{"given":"Sanja B.","family":"Turturro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew S.","family":"Najor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carl E.","family":"Ruby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melody A.","family":"Cobleigh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1172-5819","authenticated-orcid":false,"given":"Abde M.","family":"Abukhdeir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,2,25]]},"reference":[{"key":"3729_CR1","unstructured":"What are the key statistics about breast cancer? (2012) http:\/\/www.cancer.org\/Cancer\/BreastCancer\/DetailedGuide\/breast-cancer-key-statistics"},{"issue":"3","key":"3729_CR2","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/bjc.2014.264","volume":"111","author":"DM Fraser","year":"2014","unstructured":"Fraser DM, Sullivan FM, Thompson AM, McCowan C (2014) Aspirin use and survival after the diagnosis of breast cancer: a population-based cohort study. Br J Cancer 111(3):623\u2013627. doi: 10.1038\/bjc.2014.264","journal-title":"Br J Cancer"},{"issue":"3","key":"3729_CR3","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/j.1742-1241.2007.01668.x","volume":"62","author":"A Agrawal","year":"2008","unstructured":"Agrawal A, Fentiman IS (2008) NSAIDs and breast cancer: a possible prevention and treatment strategy. Int J Clin Pract 62(3):444\u2013449. doi: 10.1111\/j.1742-1241.2007.01668.x","journal-title":"Int J Clin Pract"},{"issue":"7","key":"3729_CR4","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1053\/j.gastro.2012.02.050","volume":"142","author":"FV Din","year":"2012","unstructured":"Din FV, Valanciute A, Houde VP, Zibrova D, Green KA, Sakamoto K, Alessi DR, Dunlop MG (2012) Aspirin inhibits mTOR signaling, activates AMP-activated protein kinase, and induces autophagy in colorectal cancer cells. Gastroenterology 142(7):1504\u20131515","journal-title":"Gastroenterology"},{"issue":"3","key":"3729_CR5","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1053\/j.seminoncol.2014.04.012","volume":"41","author":"B Pasche","year":"2014","unstructured":"Pasche B, Wang M, Pennison M, Jimenez H (2014) Prevention and treatment of cancer with aspirin: where do we stand? Semin Oncol 41(3):397\u2013401","journal-title":"Semin Oncol"},{"issue":"18","key":"3729_CR6","first-page":"6096","volume":"63","author":"RE Harris","year":"2003","unstructured":"Harris RE, Chlebowski RT, Jackson RD, Frid DJ, Ascenseo JL, Anderson G, Loar A, Rodabough RJ, White E, McTiernan A, Women\u2019s Health I (2003) Breast cancer and nonsteroidal anti-inflammatory drugs: prospective results from the Women\u2019s Health Initiative. Cancer Res 63(18):6096\u20136101","journal-title":"Cancer Res"},{"issue":"1","key":"3729_CR7","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1054\/bjoc.2000.1119","volume":"83","author":"CR Sharpe","year":"2000","unstructured":"Sharpe CR, Collet JP, McNutt M, Belzile E, Boivin JF, Hanley JA (2000) Nested case\u2013control study of the effects of non-steroidal anti-inflammatory drugs on breast cancer risk and stage. Br J Cancer 83(1):112\u2013120","journal-title":"Br J Cancer"},{"issue":"12","key":"3729_CR8","doi-asserted-by":"crossref","first-page":"e81970","DOI":"10.1371\/journal.pone.0081970","volume":"8","author":"P Sutcliffe","year":"2013","unstructured":"Sutcliffe P, Connock M, Gurung T, Freeman K, Johnson S, Ngianga-Bakwin K, Grove A, Gurung B, Morrow S, Stranges S, Clarke A (2013) Aspirin in primary prevention of cardiovascular disease and cancer: a systematic review of the balance of evidence from reviews of randomized trials. PLoS One 8(12):e81970","journal-title":"PLoS One"},{"issue":"9826","key":"3729_CR9","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/S0140-6736(12)60209-8","volume":"379","author":"PM Rothwell","year":"2012","unstructured":"Rothwell PM, Wilson M, Price JF, Belch JFF, Meade TW, Mehta Z (2012) Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials. Lancet 379(9826):1591\u20131601. doi: 10.1016\/s0140-6736(12)60209-8","journal-title":"Lancet"},{"issue":"9","key":"3729_CR10","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1200\/JCO.2009.22.7918","volume":"28","author":"MD Holmes","year":"2010","unstructured":"Holmes MD, Chen WY, Li L, Hertzmark E, Spiegelman D, Hankinson SE (2010) Aspirin intake and survival after breast cancer. J Clin Oncol 28(9):1467\u20131472. doi: 10.1200\/JCO.2009.22.7918","journal-title":"J Clin Oncol"},{"issue":"17","key":"3729_CR11","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1056\/NEJMoa1207756","volume":"367","author":"X Liao","year":"2012","unstructured":"Liao X, Lochhead P, Nishihara R, Morikawa T, Kuchiba A, Yamauchi M, Imamura Y, Qian ZR, Baba Y, Shima K, Sun R, Nosho K, Meyerhardt JA, Giovannucci E, Fuchs CS, Chan AT, Ogino S (2012) Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival. N Engl J Med 367(17):1596\u20131606. doi: 10.1056\/NEJMoa1207756","journal-title":"N Engl J Med"},{"issue":"34","key":"3729_CR12","doi-asserted-by":"crossref","first-page":"4297","DOI":"10.1200\/JCO.2013.50.0322","volume":"31","author":"E Domingo","year":"2013","unstructured":"Domingo E, Church DN, Sieber O, Ramamoorthy R, Yanagisawa Y, Johnstone E, Davidson B, Kerr DJ, Tomlinson IP, Midgley R (2013) Evaluation of PIK3CA mutation as a predictor of benefit from nonsteroidal anti-inflammatory drug therapy in colorectal cancer. J Clin Oncol 31(34):4297\u20134305. doi: 10.1200\/JCO.2013.50.0322","journal-title":"J Clin Oncol"},{"issue":"34","key":"3729_CR13","doi-asserted-by":"crossref","first-page":"4358","DOI":"10.1200\/JCO.2013.52.0080","volume":"31","author":"CS Fuchs","year":"2013","unstructured":"Fuchs CS, Ogino S (2013) Aspirin therapy for colorectal cancer with PIK3CA mutation: simply complex! J Clin Oncol 31(34):4358\u20134361. doi: 10.1200\/JCO.2013.52.0080","journal-title":"J Clin Oncol"},{"issue":"23","key":"3729_CR14","doi-asserted-by":"crossref","first-page":"10992","DOI":"10.1158\/0008-5472.CAN-05-2612","volume":"65","author":"SJ Isakoff","year":"2005","unstructured":"Isakoff SJ, Engelman JA, Irie HY, Luo J, Brachmann SM, Pearline RV, Cantley LC, Brugge JS (2005) Breast cancer-associated PIK3CA mutations are oncogenic in mammary epithelial cells. Cancer Res 65(23):10992\u201311000. doi: 10.1158\/0008-5472.CAN-05-2612","journal-title":"Cancer Res"},{"issue":"19","key":"3729_CR15","doi-asserted-by":"crossref","first-page":"5413","DOI":"10.1158\/1078-0432.CCR-13-0884","volume":"19","author":"JA Beaver","year":"2013","unstructured":"Beaver JA, Gustin JP, Yi KH, Rajpurohit A, Thomas M, Gilbert SF, Rosen DM, Ho Park B, Lauring J (2013) PIK3CA and AKT1 mutations have distinct effects on sensitivity to targeted pathway inhibitors in an isogenic luminal breast cancer model system. Clin Cancer Res 19(19):5413\u20135422. doi: 10.1158\/1078-0432.CCR-13-0884","journal-title":"Clin Cancer Res"},{"issue":"5670","key":"3729_CR16","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1126\/science.1096502","volume":"304","author":"Y Samuels","year":"2004","unstructured":"Samuels Y, Wang Z, Bardelli A, Silliman N, Ptak J, Szabo S, Yan H, Gazdar A, Powell SM, Riggins GJ, Willson JK, Markowitz S, Kinzler KW, Vogelstein B, Velculescu VE (2004) High frequency of mutations of the PIK3CA gene in human cancers. Science 304(5670):554","journal-title":"Science"},{"issue":"8","key":"3729_CR17","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1073\/pnas.0813351106","volume":"106","author":"JP Gustin","year":"2009","unstructured":"Gustin JP, Karakas B, Weiss MB, Abukhdeir AM, Lauring J, Garay JP, Cosgrove D, Tamaki A, Konishi H, Konishi Y, Mohseni M, Wang G, Rosen DM, Denmeade SR, Higgins MJ, Vitolo MI, Bachman KE, Park BH (2009) Knockin of mutant PIK3CA activates multiple oncogenic pathways. Proc Natl Acad Sci USA 106(8):2835\u20132840","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"3729_CR18","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1158\/0008-5472.CAN-12-1578","volume":"73","author":"GM Wang","year":"2013","unstructured":"Wang GM, Wong HY, Konishi H, Blair BG, Abukhdeir AM, Gustin JP, Rosen DM, Denmeade SR, Rasheed Z, Matsui W, Garay JP, Mohseni M, Higgins MJ, Cidado J, Jelovac D, Croessmann S, Cochran RL, Karnan S, Konishi Y, Ota A, Hosokawa Y, Argani P, Lauring J, Park BH (2013) Single copies of mutant KRAS and mutant PIK3CA cooperate in immortalized human epithelial cells to induce tumor formation. Cancer Res 73(11):3248\u20133261. doi: 10.1158\/0008-5472.CAN-12-1578","journal-title":"Cancer Res"},{"issue":"1","key":"3729_CR19","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/0003-2697(89)90710-0","volume":"182","author":"W Kueng","year":"1989","unstructured":"Kueng W, Silber E, Eppenberger U (1989) Quantification of cells cultured on 96-well plates. Anal Biochem 182(1):16\u201319","journal-title":"Anal Biochem"},{"issue":"1","key":"3729_CR20","doi-asserted-by":"crossref","first-page":"R27","DOI":"10.1186\/bcr3112","volume":"14","author":"JP Garay","year":"2012","unstructured":"Garay JP, Karakas B, Abukhdeir AM, Cosgrove DP, Gustin JP, Higgins MJ, Konishi H, Konishi Y, Lauring J, Mohseni M, Wang GM, Jelovac D, Weeraratna A, Sherman Baust CA, Morin PJ, Toubaji A, Meeker A, De Marzo AM, Lewis G, Subhawong A, Argani P, Park BH (2012) The growth response to androgen receptor signaling in ERalpha-negative human breast cells is dependent on p21 and mediated by MAPK activation. Breast Cancer Res 14(1):R27. doi: 10.1186\/bcr3112","journal-title":"Breast Cancer Res"},{"key":"3729_CR21","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1475-2867-9-7","volume":"9","author":"KM Imbalzano","year":"2009","unstructured":"Imbalzano KM, Tatarkova I, Imbalzano AN, Nickerson JA (2009) Increasingly transformed MCF-10A cells have a progressively tumor-like phenotype in three-dimensional basement membrane culture. Cancer Cell Int 9:7. doi: 10.1186\/1475-2867-9-7","journal-title":"Cancer Cell Int"},{"issue":"8","key":"3729_CR22","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/nm1087","volume":"10","author":"B Vogelstein","year":"2004","unstructured":"Vogelstein B, Kinzler KW (2004) Cancer genes and the pathways they control. Nat Med 10(8):789\u2013799. doi: 10.1038\/nm1087","journal-title":"Nat Med"},{"issue":"11","key":"3729_CR23","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1158\/0008-5472.CAN-12-1578","volume":"73","author":"GM Wang","year":"2013","unstructured":"Wang GM, Wong HY, Konishi H, Blair BG, Abukhdeir AM, Gustin JP, Rosen DM, Denmeade SR, Rasheed Z, Matsui W, Garay JP, Mohseni M, Higgins MJ, Cidado J, Jelovac D, Croessmann S, Cochran RL, Karnan S, Konishi Y, Ota A, Hosokawa Y, Argani P, Lauring J, Park BH (2013) Single copies of mutant KRAS and mutant PIK3CA cooperate in immortalized human epithelial cells to induce tumor formation. Cancer Res 73(11):3248\u20133261. doi: 10.1158\/0008-5472.CAN-12-1578","journal-title":"Cancer Res"},{"issue":"4","key":"3729_CR24","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1007\/s10620-006-9619-x","volume":"52","author":"S Lev-Ari","year":"2007","unstructured":"Lev-Ari S, Kazanov D, Liberman E, Ben-Yosef R, Arber N (2007) Down-regulation of PGE2 by physiologic levels of celecoxib is not sufficient to induce apoptosis or inhibit cell proliferation in human colon carcinoma cell lines. Dig Dis Sci 52(4):1128\u20131133. doi: 10.1007\/s10620-006-9619-x","journal-title":"Dig Dis Sci"},{"issue":"9","key":"3729_CR25","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1111\/j.1349-7006.2012.02359.x","volume":"103","author":"M Yunokawa","year":"2012","unstructured":"Yunokawa M, Koizumi F, Kitamura Y, Katanasaka Y, Okamoto N, Kodaira M, Yonemori K, Shimizu C, Ando M, Masutomi K, Yoshida T, Fujiwara Y, Tamura K (2012) Efficacy of everolimus, a novel mTOR inhibitor, against basal-like triple-negative breast cancer cells. Cancer Sci 103(9):1665\u20131671. doi: 10.1111\/j.1349-7006.2012.02359.x","journal-title":"Cancer Sci"},{"issue":"13","key":"3729_CR26","doi-asserted-by":"crossref","first-page":"4585","DOI":"10.1158\/0008-5472.CAN-04-0396","volume":"64","author":"LB Eckert","year":"2004","unstructured":"Eckert LB, Repasky GA, Ulku AS, McFall A, Zhou H, Sartor CI, Der CJ (2004) Involvement of Ras activation in human breast cancer cell signaling, invasion, and anoikis. Cancer Res 64(13):4585\u20134592. doi: 10.1158\/0008-5472.CAN-04-0396","journal-title":"Cancer Res"},{"issue":"1","key":"3729_CR27","doi-asserted-by":"crossref","first-page":"185","DOI":"10.18632\/oncotarget.1427","volume":"5","author":"F Kopp","year":"2014","unstructured":"Kopp F, Wagner E, Roidl A (2014) The proto-oncogene KRAS is targeted by miR-200c. Oncotarget 5(1):185\u2013195. doi: 10.18632\/oncotarget.1427","journal-title":"Oncotarget"},{"issue":"10","key":"3729_CR28","doi-asserted-by":"crossref","first-page":"e48208","DOI":"10.1371\/journal.pone.0048208","volume":"7","author":"S Pathi","year":"2012","unstructured":"Pathi S, Jutooru I, Chadalapaka G, Nair V, Lee SO, Safe S (2012) Aspirin inhibits colon cancer cell and tumor growth and downregulates specificity protein (Sp) transcription factors. PLoS One 7(10):e48208. doi: 10.1371\/journal.pone.0048208","journal-title":"PLoS One"},{"issue":"2","key":"3729_CR29","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1093\/ajcn\/69.2.318","volume":"69","author":"I Lares-Asseff","year":"1999","unstructured":"Lares-Asseff I, Flores-Perez J, Juarez-Olguin H, Ramirez-Lacayo M, Loredo-Abdala A, Carbajal-Rodriguez L (1999) Influence of nutritional status on the pharmacokinetics of acetylsalicylic acid and its metabolites in children with autoimmune disease. Am J Clin Nutr 69(2):318\u2013324","journal-title":"Am J Clin Nutr"},{"issue":"5","key":"3729_CR30","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/0092-8674(90)90186-I","volume":"61","author":"ER Fearon","year":"1990","unstructured":"Fearon ER, Vogelstein B (1990) A genetic model for colorectal tumorigenesis. Cell 61(5):759\u2013767","journal-title":"Cell"},{"issue":"1","key":"3729_CR31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/bdd.379","volume":"25","author":"H Juarez Olguin","year":"2004","unstructured":"Juarez Olguin H, Flores Perez J, Lares Asseff I, Loredo Abdala A, Carbajal Rodriguez L (2004) Comparative pharmacokinetics of acetyl salicylic acid and its metabolites in children suffering from autoimmune diseases. Biopharm Drug Dispos 25(1):1\u20137. doi: 10.1002\/bdd.379","journal-title":"Biopharm Drug Dispos"},{"issue":"5","key":"3729_CR32","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, Antipin Y, Reva B, Goldberg AP, Sander C, Schultz N (2012) The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov 2(5):401\u2013404. doi: 10.1158\/2159-8290.CD-12-0095","journal-title":"Cancer Discov"},{"issue":"269","key":"3729_CR33","first-page":"pl1","volume":"6","author":"J Gao","year":"2013","unstructured":"Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, Sun Y, Jacobsen A, Sinha R, Larsson E, Cerami E, Sander C, Schultz N (2013) Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal 6(269):pl1. doi: 10.1126\/scisignal.2004088","journal-title":"Sci Signal"},{"issue":"3","key":"3729_CR34","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1136\/gut.2010.217182","volume":"60","author":"S Ogino","year":"2011","unstructured":"Ogino S, Chan AT, Fuchs CS, Giovannucci E (2011) Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field. Gut 60(3):397\u2013411. doi: 10.1136\/gut.2010.217182","journal-title":"Gut"},{"issue":"23","key":"3729_CR35","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1038\/onc.2013.244","volume":"33","author":"S Ogino","year":"2014","unstructured":"Ogino S, Lochhead P, Giovannucci E, Meyerhardt JA, Fuchs CS, Chan AT (2014) Discovery of colorectal cancer PIK3CA mutation as potential predictive biomarker: power and promise of molecular pathological epidemiology. Oncogene 33(23):2949\u20132955. doi: 10.1038\/onc.2013.244","journal-title":"Oncogene"},{"issue":"12","key":"3729_CR36","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.1158\/1078-0432.CCR-12-3614","volume":"19","author":"FL Day","year":"2013","unstructured":"Day FL, Jorissen RN, Lipton L, Mouradov D, Sakthianandeswaren A, Christie M, Li S, Tsui C, Tie J, Desai J, Xu ZZ, Molloy P, Whitehall V, Leggett BA, Jones IT, McLaughlin S, Ward RL, Hawkins NJ, Ruszkiewicz AR, Moore J, Busam D, Zhao Q, Strausberg RL, Gibbs P, Sieber OM (2013) PIK3CA and PTEN gene and exon mutation-specific clinicopathologic and molecular associations in colorectal cancer. Clin Cancer Res 19(12):3285\u20133296. doi: 10.1158\/1078-0432.CCR-12-3614","journal-title":"Clin Cancer Res"},{"issue":"2\u20133","key":"3729_CR37","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/pmic.201400342","volume":"15","author":"BG Blair","year":"2015","unstructured":"Blair BG, Wu X, Zahari MS, Mohseni M, Cidado J, Wong HY, Beaver JA, Cochran RL, Zabransky DJ, Croessmann S, Chu D, Toro PV, Cravero K, Pandey A, Park BH (2015) A phosphoproteomic screen demonstrates differential dependence on HER3 for MAP kinase pathway activation by distinct PIK3CA mutations. Proteomics 15(2\u20133):318\u2013326. doi: 10.1002\/pmic.201400342","journal-title":"Proteomics"},{"key":"3729_CR38","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1038\/emm.2013.91","volume":"45","author":"BH Choi","year":"2013","unstructured":"Choi BH, Chakraborty G, Baek K, Yoon HS (2013) Aspirin-induced Bcl-2 translocation and its phosphorylation in the nucleus trigger apoptosis in breast cancer cells. Exp Mol Med 45:e47. doi: 10.1038\/emm.2013.91","journal-title":"Exp Mol Med"},{"issue":"39","key":"3729_CR39","doi-asserted-by":"crossref","first-page":"29228","DOI":"10.1074\/jbc.M602629200","volume":"281","author":"P Dikshit","year":"2006","unstructured":"Dikshit P, Chatterjee M, Goswami A, Mishra A, Jana NR (2006) Aspirin induces apoptosis through the inhibition of proteasome function. J Biol Chem 281(39):29228\u201329235. doi: 10.1074\/jbc.M602629200","journal-title":"J Biol Chem"},{"issue":"3","key":"3729_CR40","doi-asserted-by":"crossref","first-page":"909","DOI":"10.3892\/mmr.2013.1257","volume":"7","author":"F Yan","year":"2013","unstructured":"Yan F, He Q, Hu X, Li W, Wei K, Li L, Zhong Y, Ding X, Xiang S, Zhang J (2013) Direct regulation of caspase3 by the transcription factor AP2alpha is involved in aspirin induced apoptosis in MDAMB453 breast cancer cells. Mol Med Rep 7(3):909\u2013914. doi: 10.3892\/mmr.2013.1257","journal-title":"Mol Med Rep"},{"issue":"8","key":"3729_CR41","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1161\/01.STR.0000229888.55078.72","volume":"37","author":"H Endo","year":"2006","unstructured":"Endo H, Nito C, Kamada H, Yu F, Chan PH (2006) Akt\/GSK3beta survival signaling is involved in acute brain injury after subarachnoid hemorrhage in rats. Stroke 37(8):2140\u20132146. doi: 10.1161\/01.STR.0000229888.55078.72","journal-title":"Stroke"},{"issue":"6559","key":"3729_CR42","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/378785a0","volume":"378","author":"DA Cross","year":"1995","unstructured":"Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA (1995) Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378(6559):785\u2013789. doi: 10.1038\/378785a0","journal-title":"Nature"},{"issue":"7217","key":"3729_CR43","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/nature07284","volume":"455","author":"Z Wang","year":"2008","unstructured":"Wang Z, Smith KS, Murphy M, Piloto O, Somervaille TC, Cleary ML (2008) Glycogen synthase kinase 3 in MLL leukaemia maintenance and targeted therapy. Nature 455(7217):1205\u20131209. doi: 10.1038\/nature07284","journal-title":"Nature"},{"issue":"6791","key":"3729_CR44","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/35017574","volume":"406","author":"KP Hoeflich","year":"2000","unstructured":"Hoeflich KP, Luo J, Rubie EA, Tsao MS, Jin O, Woodgett JR (2000) Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation. Nature 406(6791):86\u201390. doi: 10.1038\/35017574","journal-title":"Nature"},{"issue":"3","key":"3729_CR45","doi-asserted-by":"crossref","first-page":"358","DOI":"10.4161\/cbt.11.3.14227","volume":"11","author":"MJ Higgins","year":"2011","unstructured":"Higgins MJ, Beaver JA, Wong HY, Gustin JP, Lauring JD, Garay JP, Konishi H, Mohseni M, Wang GM, Cidado J, Jelovac D, Cosgrove DP, Tamaki A, Abukhdeir AM, Park BH (2011) PIK3CA mutations and EGFR overexpression predict for lithium sensitivity in human breast epithelial cells. Cancer Biol Ther 11(3):358\u2013367","journal-title":"Cancer Biol Ther"},{"issue":"6","key":"3729_CR46","first-page":"509","volume":"2","author":"S Dihlmann","year":"2003","unstructured":"Dihlmann S, Klein S, Doeberitz Mv M (2003) Reduction of beta-catenin\/T-cell transcription factor signaling by aspirin and indomethacin is caused by an increased stabilization of phosphorylated beta-catenin. Mol Cancer Ther 2(6):509\u2013516","journal-title":"Mol Cancer Ther"},{"issue":"49","key":"3729_CR47","doi-asserted-by":"crossref","first-page":"6447","DOI":"10.1038\/sj.onc.1209658","volume":"25","author":"CL Bos","year":"2006","unstructured":"Bos CL, Kodach LL, van den Brink GR, Diks SH, van Santen MM, Richel DJ, Peppelenbosch MP, Hardwick JC (2006) Effect of aspirin on the Wnt\/beta-catenin pathway is mediated via protein phosphatase 2A. Oncogene 25(49):6447\u20136456. doi: 10.1038\/sj.onc.1209658","journal-title":"Oncogene"},{"issue":"3","key":"3729_CR48","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1158\/1535-7163.MCT-06-0665","volume":"6","author":"M Kunnimalaiyaan","year":"2007","unstructured":"Kunnimalaiyaan M, Vaccaro AM, Ndiaye MA, Chen H (2007) Inactivation of glycogen synthase kinase-3beta, a downstream target of the raf-1 pathway, is associated with growth suppression in medullary thyroid cancer cells. Mol Cancer Ther 6(3):1151\u20131158. doi: 10.1158\/1535-7163.MCT-06-0665","journal-title":"Mol Cancer Ther"},{"issue":"7","key":"3729_CR49","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/labinvest.2015.49","volume":"95","author":"G Maity","year":"2015","unstructured":"Maity G, De A, Das A, Banerjee S, Sarkar S, Banerjee SK (2015) Aspirin blocks growth of breast tumor cells and tumor-initiating cells and induces reprogramming factors of mesenchymal to epithelial transition. Lab Invest 95(7):702\u2013717. doi: 10.1038\/labinvest.2015.49","journal-title":"Lab Invest"},{"issue":"5","key":"3729_CR50","first-page":"1277","volume":"23","author":"FP Lloyd Jr","year":"2003","unstructured":"Lloyd FP Jr, Slivova V, Valachovicova T, Sliva D (2003) Aspirin inhibits highly invasive prostate cancer cells. Int J Oncol 23(5):1277\u20131283","journal-title":"Int J Oncol"},{"issue":"4","key":"3729_CR51","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s10616-012-9520-8","volume":"65","author":"HX Qin","year":"2013","unstructured":"Qin HX, Yang J, Cui HK, Li SP, Zhang W, Ding XL, Xia YH (2013) Synergistic antitumor activity of reversine combined with aspirin in cervical carcinoma in vitro and in vivo. Cytotechnology 65(4):643\u2013653. doi: 10.1007\/s10616-012-9520-8","journal-title":"Cytotechnology"},{"issue":"21","key":"3729_CR52","doi-asserted-by":"crossref","first-page":"8275","DOI":"10.1158\/0008-5472.CAN-09-1067","volume":"69","author":"MI Vitolo","year":"2009","unstructured":"Vitolo MI, Weiss MB, Szmacinski M, Tahir K, Waldman T, Park BH, Martin SS, Weber DJ, Bachman KE (2009) Deletion of PTEN promotes tumorigenic signaling, resistance to anoikis, and altered response to chemotherapeutic agents in human mammary epithelial cells. Cancer Res 69(21):8275\u20138283. doi: 10.1158\/0008-5472.CAN-09-1067","journal-title":"Cancer Res"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-016-3729-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-016-3729-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-016-3729-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,4]],"date-time":"2019-09-04T20:15:56Z","timestamp":1567628156000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-016-3729-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["3729"],"URL":"https:\/\/doi.org\/10.1007\/s10549-016-3729-8","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2]]}}}